glp 1 drugs depression Most GLP-1 Medications Correlated with a Lower Likelihood of Anxiety and Diagnoses Ozempic and other GLP-1 drugs

Clinical Trial Evidence: Landmark cardiovascular outcome trials (CVOTs) like the SELECT trial (for semaglutide) have shown a significant reduction in major adverse cardiovascular events (MACE), including heart attack, stroke, and cardiovascular death

Adequate fluid intake supports digestion and helps offset common side effects like constipation

Lifestyle interventions, alternative anti-obesity medications, and bariatric surgery offer different approaches for weight loss and may provide useful context for evaluating the overall impact of GLP-1 RAs

Therefore, impaired autophagy may contribute to the AD pathogenesis (73)

A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American Heart Association